By Editor , 1 October 2026
Brogidirsen Shows 5-Year Motor Function Benefit in DMD Trial

Paramus, N.J. – October 01, 2026 -- NS Pharma, Inc. reported 5-year efficacy and safety data showing its investigational therapy brogidirsen maintained or improved motor function in Duchenne muscular dystrophy (DMD) patients amenable to exon 44 skipping, with zero treatment discontinuations across the study period.

By Editor , 1 October 2026
Nanoscope's MOGENRY Gains Priority Review in Japan for IRD Patients

Dallas – October 01, 2026 -- Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has accepted and granted priority review to Nanoscope Therapeutics' New Drug Application for MOGENRY (sonpiretigene isteparvovec, MCO-010), an optogenetic gene therapy for inherited retinal dystrophies (IRDs). If approved by the Ministry of Health, Labour and Welfare, MOGENRY would become the first disease-agnostic treatment available to IRD patients in Japan, a condition caused by mutations across more than 250 genes that leads to progressive photoreceptor loss and blindness.

By Editor , 1 October 2026
TIER IV Joins Arm Total Design to Scale Autoware on Arm Chips

Tokyo – September 30, 2026 -- TIER IV, the developer behind the open-source autonomous driving software Autoware, has joined Arm Total Design for Physical AI, a move aimed at expanding Autoware's availability across Arm-based system-on-chips and in-vehicle computing platforms.

By Editor , 30 September 2026
Aflac to Report Q3 2026 Earnings November 4, Call Set for Nov. 5

Columbus, Georgia – September 30, 2026 -- Aflac Incorporated (NYSE: AFL) will release third-quarter 2026 financial results after market close on Wednesday, November 4, 2026.

Earnings materials post same day as market close

The quarterly earnings release and financial supplement will be published on the company's investor relations site, investors.aflac.com, alongside a financial update video from Senior Executive Vice President and Chief Financial Officer Max K. Brodén.

By Editor , 30 September 2026
CFS Signs Largest-Ever HTS Tape Deal With Fujikura for ARC Fusion Plants

Devens, Mass. and Tokyo – September 30, 2026 -- Commonwealth Fusion Systems (CFS) has agreed to purchase more than 10,000 km (3 GA-m) of high-temperature superconducting (HTS) tape from Japan's Fujikura Ltd., in what the companies describe as the largest supply agreement of its kind for HTS tape.

By Editor , 30 September 2026

San Antonio – September 30, 2026 -- NTT TechnoCross has secured Frost & Sullivan's 2026 Japanese Company of the Year Recognition in privileged access management for the third consecutive year, citing its unified governance platform for enterprise cybersecurity.

By Editor , 30 September 2026
TIER IV Launches Wide-Angle Cameras for Level 4 Autonomy

Tokyo – September 30, 2026 -- TIER IV, the developer behind the open-source Autoware platform, will begin sales on September 30, 2026, of two new automotive-grade cameras built for commercial-scale Level 4 autonomous driving. The C1-120MP and C2-120MP feature a 120-degree wide-angle lens designed to close peripheral blind spots around autonomous vehicles.

By Editor , 29 September 2026

Kyoto – September 29, 2026 -- Nuvoton Technology Corporation Japan (NTCJ) will begin sampling its KA85010UA battery monitoring IC in January 2027, a 26-cell chip that integrates electrochemical impedance spectroscopy (EIS) directly on-chip while cutting PCB temperature rise during measurements by approximately 93% compared with conventional methods.